A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications.
about
Defining response to anti-VEGF therapies in neovascular AMDThe safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic reviewA safety study of high concentration and high frequency intravitreal injection of conbercept in rabbitsTeleophthalmology with optical coherence tomography imaging in community optometry. Evaluation of a quality improvement for macular patients.Action on AMD. Optimising patient management: act now to ensure current and continual delivery of best possible patient care.Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicinesPost-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.Transformational change: nurses substituting for ophthalmologists for intravitreal injections - a quality-improvement report.Optimising assessment intervals improves visual outcomes in ranibizumab-treated age-related neovascular degeneration: using the stability phase as a benchmark.Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK.Therapeutic efficacy of bevacizumab for age-related macular degeneration: what are the implications of CATT for routine management?Rate of vision loss in neovascular age-related macular degeneration explored.
P2860
Q26996510-75137B7F-F31D-49F5-8550-74008F9D8498Q27013836-771EC10C-7E75-41B8-BCC8-210F472E4EE5Q33674476-2A5B11B9-5CAB-4A56-BBAB-3AAAAD976956Q35609936-B477A8F7-0F46-472A-AF92-B7F25793AFBEQ35797079-96E986A6-0CBA-4B17-A1A7-738B06FA2E08Q36374429-0954097B-3F3B-4E0C-AADC-9678EC87AB97Q36468197-CEDBC615-A0AB-41F7-AB45-4393C791C854Q37721864-CA3D2C3E-D450-469B-891F-0DED3796B827Q38099573-F301AB4D-9033-4E1E-9150-53C21C08E0CFQ44558337-AE0F704A-F5FC-44F6-81E6-893168CFC2E2Q46526244-51FDE9BF-2C75-4610-B3C4-AAD70E08BA0EQ53666477-618FB43F-BC41-44BF-8A28-1293F2532189
P2860
A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A review of safety incidents i ...... factor inhibitor medications.
@ast
A review of safety incidents i ...... factor inhibitor medications.
@en
type
label
A review of safety incidents i ...... factor inhibitor medications.
@ast
A review of safety incidents i ...... factor inhibitor medications.
@en
prefLabel
A review of safety incidents i ...... factor inhibitor medications.
@ast
A review of safety incidents i ...... factor inhibitor medications.
@en
P2860
P356
P1433
P1476
A review of safety incidents i ...... h factor inhibitor medications
@en
P2093
P2860
P2888
P304
P356
10.1038/EYE.2011.89
P50
P577
2011-04-29T00:00:00Z